Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
J. Clin. Invest. Juliana Hamzah, et al. 118:1691
doi:10.1172/JCI33201 [Go to this article.]

Problems with a PDF?